PhD Projects
Primary Project
Characterizing small non-coding RNAs in the human
placenta
The human placenta is indispensible for the growth of the fetus and
for the healthy progression of pregnancy. It serves as the interface
between the mother and baby for all water, nutrient, gas, and waste
exchange; as such regulation of gene expression is tightly regulated at
every stage. Gene regulation is carried out by a number of factors, and
expression modulation by small non-coding RNAs (sncRNAs) is one such
regulatory mechanism. Exclusive
placentally-expressed sncRNA loci in the placenta have been
identified, however, studies have routinely focused on only one
species of sncRNA (microRNAs), largely due to sample availability.
My project aims at:
- Characterizing human placental sncRNA species in whole tissue and 4
placental cell types (cytotrophoblasts, endothelial cells, stromal
cells, HofBauer cells)
- Investigating novel placental sncRNAs
- Assessing biological (cell type, trimester, sex of the fetus,
ancestry, depression and anti-depressant status of the mother, stress)
and technical variables (method of extraction and various sequencing
metrics) driving expression
- Testing association between sample-matched DNA methyaltion and
sncRNA expression
- Examining shared expression characteristics between placenetal
development and cancer
Data:
low-input small-RNA-seq, DNA methylation
Software:
R, GSEA, pathway enrichment
Code:
Project Impact:
Collaborations
1. BC Children’s Hospital Research Institute / The Ted Steiner Lab
Project: An IBD-mimic human colonoid chronic-injury
model
Intestinal cells undergo regeneration after acute injury. However,
the feasibility and capacity of these cells to undergo repeated renewal
and regeneration on chronic injury is still not well understood. Using
intestinal epithelial cells collected from 2 human patients, colonoid
organoids were generated in the lab and were further subjected to rounds
of induced damage, inflammation and rescue to observe the renewal
mechanisms of these cells
I was recruited as a Bioinformatician for this exploratory
project to analyze their RNA-seq data, for which I was given
second-authorship on the respective manuscript
Data:
Human and murine RNA-seq Software:
R,
GSEA
Code:
- Geneset
enrichment analysis
- GEO
accession
Publication:
Second-author
in Cell Reports
2. Centre for Heart Lung Innovation: St. Paul’s Hospital / The Decheng Yang
Lab
Project: Role of NFAT5 in the pathogenesis of
coxsackievirus-induced myocarditis
I was recruited to analyse their bioinformatics data in the POC
study, which also availed me to undertake a project related to the
scientific area which intersts me the most - cardiovasuclar
disease
Data:
Murine RNA-seq
Software:
R
Publication:
Basic
Research in Cardiology
3. BC Children’s Hospital Research Institute / The Gregor Reid Lab
Project: Investigating the dynamic immunophenotypic cell
population changes during childhood acute lymphoblastic leukemia (ALL)
relapse
I trained the first-author physician-scientist in R
Programming
Data:
Human RNA-seq
Software:
R
Publication:
Manuscript submitted to Nature Cancer
Project: Telmisartan treated tumours show an improved
response to radiaition therapy
In progress: Follow-up validation experiments of in-silico
results
Data:
Human + murine single-cell RNA-seq
Software:
R
5. Djavad Mowafaghian Centre for Brain Health / The Yu
Tian Wang Lab
Notch1 signaling plays an essential role in metabolic
rewiring in docetaxel resistance prostate cancer
In progress: Manuscript writing
Data:
Human RNA-seq
Software:
R
Master’s Project
Comparing the Genetic Architecture of Lipid Traits between
Populations
The majority of Genome-wide Association Studies, even now, focus on
Caucasian, European populations. Genetic differences exist people of
differing populations, where people of a certain ancestry or ethnicity
can have genetic variants not present in those of European popualtions.
These variants can lead to variable gene expression, as well as a
differential response to drugs admistered. Hence, the resulsts of these
single-poulation centric studies cannot be extrapolated to different
populations. There is, therefore, an increased need to conduct such
genome-wide studies in several other populations, along with accounting
for population differences in large-scale studies.
I collected GWAS summary statistics of three lipid
(cholesterol) biomarkers from seven different populations (British, two
Greek isolates, Chinese, Japanese, East Asian, Ugandan) calculated the
Polygeneic Risk Scores (PRSs) of each individual using the commonly
overlapping lipid SNPs to assess if these scores varied across the
populations. The heritability as well as trans-ancestral correlation was
also calculated. The measured blood lipid biomarker levels were then
examined across the genetic scores, to investigate the correlation
between the blood lipid levels of one biomarker against the genetic
score of another (biomarker-score cross association).
Data:
Human SNP (GWAS)
Software
: UNIX, command-line R, PLINK, GEMMA, Popcorn
Results
:
- The majority of European CVD/lipid loci overlap with the Japanese,
Chinese, Greek-isolate, and African Ugandan populations.
- HDL biomarker/score showed an inverse relationship with LDL
biomarker score; LDL and Triglycerides had a linear relationship, except
for in the Ugandan population where triglyceride score did not correlate
with biomarker score.
- The two Greek-isolate populations showed near perfect heritability
and trans-ethnic correlation with the UK population, same as the
Japanese and Chinese population with the East Asian population.
Project Impact
:
Undergraduate Summer Research
Using WNT5A Expression to Characterize Development in the
Human Gut
The WNT
genes are known to participate in genetic pathways involved in cell
patterning, signalling, and proliferation during development. WNT5A in
particular is invloved in a number of syndromes
which are caused by abnormal cell signalling or growth. The gut (made up
of the esophagus, intestines, and anus) is one of the organs that grows
and elongates the most during embryonic develpement.
Using immunohistochemistry, I measured the presence of the
WNT5A protein the human embryonic gut at Carnegie
Stage 20 (~50 days post conception).
Project Impact
: